Stay updated on Itolizumab in Uncontrolled Asthma Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.

Latest updates to the Itolizumab in Uncontrolled Asthma Clinical Trial page
- Check6 days agoChange DetectedThe page now includes a 'Show glossary' option and adds the 'Last Update Submitted that Met QC Criteria' metadata with revision 'v3.4.0'. It removes the older 'Last Update Submitted that met QC Criteria' field, the 'No FEAR Act data' item, and the previous revision 'v3.3.4'.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAn administrative revision note was added: Revision: v3.3.4, replacing the previous Revision: v3.3.3. There is no indication that study content, eligibility criteria, or results were changed.SummaryDifference0.1%

- Check41 days agoChange DetectedFooter now displays Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed; the previous Revision: v3.3.2 label is no longer shown.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0; no substantive content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedRemoved the global funding-status notice stating information may not be up to date and inquiries may be delayed until appropriations are enacted. The NIH Clinical Center operating status links and status update references (cc.nih.gov and opm.gov) were also removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedAdministrative updates to the study record, including updated dates and document links; core study information remains unchanged.SummaryDifference0.4%

Stay in the know with updates to Itolizumab in Uncontrolled Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Uncontrolled Asthma Clinical Trial page.